The estimated Net Worth of Jacqueline K Barton is at least $1.84 Million dollars as of 3 May 2022. Jacqueline Barton owns over 2,223 units of Gilead Sciences stock worth over $1,448,745 and over the last 19 years he sold GILD stock worth over $0. In addition, he makes $394,977 as Independent Director at Gilead Sciences.
Jacqueline has made over 10 trades of the Gilead Sciences stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 2,223 units of GILD stock worth $179,930 on 3 May 2022.
The largest trade he's ever made was exercising 6,050 units of Gilead Sciences stock on 3 November 2016 worth over $253,919. On average, Jacqueline trades about 999 units every 148 days since 2006. As of 3 May 2022 he still owns at least 17,899 units of Gilead Sciences stock.
You can see the complete history of Jacqueline Barton stock trades at the bottom of the page.
Dr. Jacqueline K. Barton Ph.D. serves as Independent Director of the Company. serves as Independent Director of the Company. Dr. Barton is the John G. Kirkwood and Arthur A. Noyes Professor of Chemistry in the Division of Chemistry and Chemical Engineering at the California Institute of Technology, where she has been a member of the faculty for nearly 30 years and served as the Norman Davidson Leadership Chair of the division from 2009 to 2019. She is a member of the board of directors of Dow Inc., and previously served on the board of directors and Materials Advisory Committee of DowDupont Inc. and the board of directors of The Dow Chemical Company. Dr. Barton also founded and served on the board of directors of GeneOhm Sciences Inc., a molecular diagnostics company acquired by Becton, Dickinson and Company, and was a member of Gilead’s Scientific Advisory Board from 1989 to 2007. She is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Philosophical Society. In 2011, Dr. Barton received the 2010 National Medal of Science for her discovery of new chemistry of the DNA helix, and in 2015, she received the Priestley Medal, the highest award of the American Chemical Society.
As the Independent Director of Gilead Sciences, the total compensation of Jacqueline Barton at Gilead Sciences is $394,977. There are 14 executives at Gilead Sciences getting paid more, with Daniel O'Day having the highest compensation of $29,107,900.
Jacqueline Barton is 67, he's been the Independent Director of Gilead Sciences since 2018. There are 3 older and 21 younger executives at Gilead Sciences. The oldest executive at Gilead Sciences, Inc. is Richard Whitley, 74, who is the Independent Director.
Jacqueline's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 21 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger, and John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: